FDA Inspection 886830 — Long Island Pharmaceuticals LLC

Long Island Pharmaceuticals LLC — FEI 3010342071

The FDA completed an inspection of Long Island Pharmaceuticals LLC on July 3, 2014 in Ronkonkoma, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 11 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 3, 2014
Fiscal Year
2014
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Ronkonkoma, NY (United States)

Citations

IDCFRDescription
1544221 CFR 111.15(b)(1)Physical plant - clean and sanitary
1551121 CFR 111.27(d)Equipment - maintain - general
1564121 CFR 111.453Written procedures - holding
1566221 CFR 111.303Written procedures - laboratory operations
1567521 CFR 111.315(b)Sampling plans; establish, follow
1579721 CFR 111.553Written procedures - product complaint
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1586921 CFR 111.75(c)Specifications met - verify; finished batch
1592721 CFR 111.103Written procedures - quality control operations
1596321 CFR 111.113(b)(2)Quality control - reject; specification not met
1598421 CFR 111.123(a)(8)Quality control - finished batch, distribution